A New Mathematical Model for the Interpretation of Translational Research Evaluating Six CTLA-4 Polymorphisms in High-Risk Melanoma Patients Receiving Adjuvant Interferon

• Petr Pancoska,

  Affiliation Department of Medicine, Center for Clinical Pharmacology, Center for Craniofacial and Dental Genetics, University of Pittsburgh, Pittsburgh, Pennsylvania, United States of America

  ⨯
• John M. Kirkwood,

  Affiliation Department of Medicine, Hillman Cancer Center, University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania, United States of America

  ⨯
• Spyros Bouros,

  Affiliation 1st Department of Medicine, Medical School, University of Athens, Athens, Greece

  ⨯
• Maria Spyropoulou-Vlachou,

  Affiliation Department of Immunology, National Tissue Typing Center, General Hospital of Athens, Athens, Greece

  ⨯
• Eirini Pectasides,

  Affiliation 1st Department of Medicine, Medical School, University of Athens, Athens, Greece

  ⨯
• Dimosthenis Tsoutsos,

  Affiliation Department of Plastic Surgery and Microsurgery, G. Gennimatas General Hospital of Athens, Athens, Greece

  ⨯
• Aristidis Polyzos,

  Affiliation 1st Department of Medicine, Medical School, University of Athens, Athens, Greece

  ⨯
• Christos Markopoulos,

  Affiliation 1st Department of Medicine, Medical School, University of Athens, Athens, Greece

  ⨯
• Petros Panagiotou,

  Affiliation Department of Plastic Surgery and Microsurgery, G. Gennimatas General Hospital of Athens, Athens, Greece

  ⨯
• Ourania Castana,

  Affiliation Department of Plastic Surgery, Evangelismos General Hospital of Athens, Athens, Greece

  ⨯
• Dimitrios Bafaloukos,

  Affiliation Hellenic Cooperative Oncology Group, Data Office, Athens, Greece

  ⨯
• George Fountzilas,

  Affiliation Hellenic Cooperative Oncology Group, Data Office, Athens, Greece

  ⨯
• Helen Gogas

  * E-mail: hgogas@hol.gr

  Affiliation 1st Department of Medicine, Medical School, University of Athens, Athens, Greece

  ⨯